Role of G-protein coupled receptors in cardiovascular diseases

Yuanqiang Li1, Boyu Li2, Wei-Dong Chen3,4

  • 1State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Insights

G-protein-coupled receptors (GPCRs) are crucial in cardiovascular diseases (CVDs), influencing heart and vascular functions. Understanding GPCRs offers new therapeutic targets for treating these widespread conditions.

Area of Science:

  • Pharmacology
  • Cardiology
  • Molecular Biology

Background:

  • Cardiovascular diseases (CVDs) are the leading global cause of mortality, responsible for approximately 30% of annual deaths worldwide.
  • G-protein-coupled receptors (GPCRs) are integral cell surface receptors critical for regulating physiological and pathological cellular processes.
  • Existing CVD treatments, including beta-blockers, and a significant portion of cardiovascular drugs target GPCRs, highlighting their therapeutic importance.

Purpose of the Study:

  • To review and discuss the multifaceted roles of GPCRs in cardiovascular system function, encompassing both vascular and cardiac perspectives.
  • To analyze the complex regulatory mechanisms of multiple GPCRs in the context of vascular and heart diseases.
  • To identify novel therapeutic strategies and drug development opportunities for CVDs based on GPCR research.

Main Methods:

  • Literature review and synthesis of existing research on GPCR structure and function in cardiovascular contexts.
  • Analysis of data linking GPCR activity to cardiovascular physiology and pathology.
  • Exploration of therapeutic interventions targeting GPCRs for CVD treatment.

Main Results:

  • GPCRs play a pivotal role in regulating cardiovascular system functions, affecting both the heart and vasculature.
  • Evidence indicates that numerous GPCRs are implicated in the development and progression of various cardiovascular diseases.
  • Targeting GPCRs has proven effective in current CVD therapies and represents a significant area for future drug development.

Conclusions:

  • GPCRs are indispensable regulators of cardiovascular health and disease.
  • A comprehensive understanding of GPCRs in cardiovascular diseases is essential for advancing treatment options.
  • This review provides a foundation for developing innovative drugs targeting GPCRs to combat cardiovascular diseases effectively.

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.4K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.3K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
4.6K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
2.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K